MedPath

Clobetasol Propionate

CLOBETASOL PROPIONATE OINTMENT USP, 0.05%

Approved
Approval ID

a862de41-1500-9136-e053-2a95a90a6080

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 3, 2023

Manufacturers
FDA

AvKARE

DUNS: 796560394

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clobetasol propionate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-077
Application NumberANDA209701
Product Classification
M
Marketing Category
C73584
G
Generic Name
clobetasol propionate
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 3, 2023
FDA Product Classification

INGREDIENTS (4)

PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SORBITAN SESQUIOLEATEInactive
Code: 0W8RRI5W5A
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
CLOBETASOL PROPIONATEActive
Quantity: 0.5 mg in 1 g
Code: 779619577M
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clobetasol Propionate - FDA Drug Approval Details